AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20079178 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (546 patients)
Number of subjects: 1062
Study 20079178 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention group (516 patients)
Number of subjects: 1062
Study 20079178 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely high risk subgroup (19 patients)
Number of subjects: 1062
Study 20079178 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and nonintervention)
Number of subjects: 1062
Study 17576513 — intervention group
Group type: EXPERIMENTAL
Intervention: Handholding
Number of subjects: 21
Study 17576513 — intervention group
Group type: EXPERIMENTAL
Intervention: Walker
Number of subjects: 21
Study 17576513 — intervention group
Group type: EXPERIMENTAL
Intervention: Guarding
Number of subjects: 21
Study 15310314 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% fructose solution (0.5 mL)
Number of subjects: 34
Study 15310314 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% glucose solution (0.5 mL)
Number of subjects: 34
Study 15310314 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile water, 0.5 mL)
Number of subjects: 34
Study 11669411 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg and then 8 mg daily)
Number of subjects: 12236
Study 11669411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12236
Study 9543561 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam-beta-cyclodextrin (PBCD)
Number of subjects: 107
Study 9543561 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow release diclofenac (DCL)
Number of subjects: 107
Study 8149571 — intervention group
Group type: EXPERIMENTAL
Intervention: Disinfection solutions (three different systems)
Number of subjects: 44
Study 3146553 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin 10 mg/24 hours
Number of subjects: 10
Study 3146553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31309323 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate supplementation (CHO)
Number of subjects: 50
Study 31309323 — intervention group
Group type: COMPARATOR
Intervention: Preoperative fasting (FAST)
Number of subjects: 50
Study 28592751 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (atorvastatin 10‐20 mg and ezetimibe 10 mg/day; Group C)
Number of subjects: 131
Study 28592751 — intervention group
Group type: COMPARATOR
Intervention: Statin monotherapy (atorvastatin 10‐20 mg; Group M)
Number of subjects: 131
Study 24621985 — intervention group
Group type: EXPERIMENTAL
Intervention: AT/RT3 (Aerobic Training + Resistance Training, 3 sets)
Number of subjects: 72
Study 24621985 — intervention group
Group type: EXPERIMENTAL
Intervention: AT/RT1 (Aerobic Training + Resistance Training, 1 set)
Number of subjects: 72
Study 24621985 — intervention group
Group type: COMPARATOR
Intervention: AT (Aerobic Training alone)
Number of subjects: 72
Study 23474003 — intervention group
Group type: EXPERIMENTAL
Intervention: BreatheMAX device (humidification and oscillation of inspired air)
Number of subjects: 15
Study 23474003 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (no humidification and oscillation)
Number of subjects: 15
Study 21439049 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental support programme including health information brochure, motivational interviewing sessions, and teacher-led activities.
Number of subjects: 242
Study 21439049 — intervention group
Group type: COMPARATOR
Intervention: Control group (no parental support programme).
Number of subjects: 242
Study 21439049 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental support programme.
Number of subjects: 242
Study 20084878 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-dried live attenuated varicella vaccine
Number of subjects: 0
Study 20084878 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what control was used)
Number of subjects: 0
Study 16425096 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunscreen use during workdays
Number of subjects: 2660
Study 16425096 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunscreen use during non-working days
Number of subjects: 2660
Study 16425096 — intervention group
Group type: EXPERIMENTAL
Intervention: Widebrim hat use during workdays
Number of subjects: 2660
Study 16425096 — intervention group
Group type: EXPERIMENTAL
Intervention: Widebrim hat use during non-working days
Number of subjects: 2660
Study 15461825 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 0.2 mg/kg IV
Number of subjects: 34
Study 15461825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 14606018 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of rugae in the gastric corpus
Number of subjects: 488
Study 14606018 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of visible vessels in the gastric corpus
Number of subjects: 488
Study 14606018 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of visible vessels in the antrum
Number of subjects: 488
Study 14606018 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic features (alone or in combination)
Number of subjects: 488
Study 11189671 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly 2-hour visit and walk by volunteers for 9 months (experimental group)
Number of subjects: 21
Study 11189671 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list for 6 weeks)
Number of subjects: 21
Study 8956701 — intervention group
Group type: EXPERIMENTAL
Intervention: Cafetière coffee
Number of subjects: 46
Study 8956701 — intervention group
Group type: COMPARATOR
Intervention: Filtered coffee
Number of subjects: 46
Study 1579647 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction in personal control over noise via the availability of a sound conditioner
Number of subjects: 105
Study 1579647 — intervention group
Group type: EXPERIMENTAL
Intervention: No instruction in personal control over noise
Number of subjects: 105
Study 1579647 — intervention group
Group type: COMPARATOR
Intervention: Quiet conditions
Number of subjects: 105
Study 1579647 — intervention group
Group type: EXPERIMENTAL
Intervention: CCU sounds
Number of subjects: 105
Study 2865292 — intervention group
Group type: COMPARATOR
Intervention: Cephazolin (1 g)
Number of subjects: 168
Study 2865292 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan (1 g)
Number of subjects: 168
Study 30597582 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Awareness condition
Number of subjects: 121
Study 30597582 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer (other-awareness) condition
Number of subjects: 121
Study 30597582 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 121
Study 29235555 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain brown rice
Number of subjects: 10
Study 29235555 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-amylose brown rice
Number of subjects: 10
Study 29235555 — intervention group
Group type: EXPERIMENTAL
Intervention: High-amylose brown rice
Number of subjects: 10
Study 29235555 — intervention group
Group type: COMPARATOR
Intervention: White rice
Number of subjects: 10
Study 27495071 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Coaching (CBC) program
Number of subjects: 80
Study 27495071 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 24842541 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing ceremony
Number of subjects: 25
Study 21448709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (vitamin C) 2 g during myomectomy
Number of subjects: 102
Study 21448709 — intervention group
Group type: COMPARATOR
Intervention: Control group (myomectomy without interventions)
Number of subjects: 102
Study 19747888 — intervention group
Group type: EXPERIMENTAL
Intervention: FOBT
Number of subjects: 9889
Study 19747888 — intervention group
Group type: COMPARATOR
Intervention: OC
Number of subjects: 9889
Study 18767509 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc oxide-eugenol (ZOE)
Number of subjects: 42
Study 18767509 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide/iodoform paste (Vitapex)
Number of subjects: 42
Study 15975312 — intervention group
Group type: EXPERIMENTAL
Intervention: Shengxueling (SXL)
Number of subjects: 86
Study 15975312 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 86
Study 12708881 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering with perindopril 2mg/indapamide 0.625 mg then perindopril 4 mg/indapamide 1.25mg
Number of subjects: 10000
Study 12708881 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive sulphonylurea‐based glucose control regimen (target HbA(1c) </= 6.5%)
Number of subjects: 10000
Study 12708881 — intervention group
Group type: COMPARATOR
Intervention: Usual guidelines‐based therapy
Number of subjects: 10000
Study 12708881 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo for blood pressure lowering
Number of subjects: 10000
Study 9885791 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (subanesthetic doses)
Number of subjects: 15
Study 8574629 — intervention group
Group type: EXPERIMENTAL
Intervention: Paget's disease patients managed in a rheumatology department
Number of subjects: 700
Study 8574629 — intervention group
Group type: COMPARATOR
Intervention: Intravenous urograms in urology department patients
Number of subjects: 700
Study 1960829 — intervention group
Group type: EXPERIMENTAL
Intervention: 8.0 km/h group (aerobic walkers)
Number of subjects: 102
Study 1960829 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4 km/h group (brisk walkers)
Number of subjects: 102
Study 1960829 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.8 km/h group (strollers)
Number of subjects: 102
Study 1960829 — intervention group
Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 102
Study 7128954 — intervention group
Group type: EXPERIMENTAL
Intervention: Keto analogs of branched-chain amino acids (15.24 g orally over 4 weeks)
Number of subjects: 12
Study 7128954 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral)
Number of subjects: 12
Study 31534016 — intervention group
Group type: EXPERIMENTAL
Intervention: HVTN 097 vaccine regimen
Number of subjects: 0
Study 31534016 — intervention group
Group type: COMPARATOR
Intervention: RV144 vaccine regimen
Number of subjects: 0
Study 28369286 — intervention group
Group type: COMPARATOR
Intervention: D+Ex- (Vitamin D + Exercise)
Number of subjects: 409
Study 28369286 — intervention group
Group type: COMPARATOR
Intervention: D-Ex+ (Vitamin D + No Exercise)
Number of subjects: 409
Study 28369286 — intervention group
Group type: COMPARATOR
Intervention: D+Ex+ (Vitamin D + Exercise)
Number of subjects: 409
Study 28369286 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise groups (D+Ex- and D-Ex+)
Number of subjects: 409
Study 28369286 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 409
Study 26374467 — intervention group
Group type: EXPERIMENTAL
Intervention: 14‐Fr silicone tubing with balloon
Number of subjects: 284
Study 26374467 — intervention group
Group type: COMPARATOR
Intervention: 14‐Fr silicone tubing without balloon
Number of subjects: 284
Study 23907810 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD3199 (480 µg)
Number of subjects: 37
Study 23907810 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD3199 (1920 µg)
Number of subjects: 37
Study 23907810 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (36 µg)
Number of subjects: 37
Study 23907810 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD3199 (480 µg) and 1920 µg
Number of subjects: 37
Study 23907810 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD3199
Number of subjects: 37
Study 23907810 — intervention group
Group type: COMPARATOR
Intervention: Formoterol
Number of subjects: 37
Study 23907810 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD3199 and Formoterol
Number of subjects: 37
Study 21543191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT) with Rehacom® software, n=8
Number of subjects: 17
Study 21543191 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-CRT), n=9
Number of subjects: 17
Study 20082253 — intervention group
Group type: EXPERIMENTAL
Intervention: Gubitong Recipe (GBT) Decoction, one dose every day for eight weeks
Number of subjects: 90
Study 20082253 — intervention group
Group type: COMPARATOR
Intervention: Glucosamine sulfate 500 mg thrice a day for eight weeks (Control)
Number of subjects: 90
Study 16914458 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint crisis plan
Number of subjects: 160
Study 16914458 — intervention group
Group type: COMPARATOR
Intervention: Standardised service information
Number of subjects: 160
Study 15624743 — intervention group
Group type: EXPERIMENTAL
Intervention: LED photomodulation using the Gentlewaves full panel 590 nm high energy LED array with a specific sequence or code of pulsing in the millisecond domain
Number of subjects: 93
Study 15624743 — intervention group
Group type: EXPERIMENTAL
Intervention: LED photomodulation
Number of subjects: 93
Study 11180037 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of fluvoxamine per day for 5 days
Number of subjects: 14
Study 11180037 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg of fluvoxamine per day for 5 days
Number of subjects: 14
Study 9735531 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing ambient lenses
Number of subjects: 18
Study 9735531 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 18
Study 7986789 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw frozen, blanched or canned carrots (15 g dietary fibre/d)
Number of subjects: 24
Study 7986789 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw or raw frozen carrots (15 g dietary fibre/d)
Number of subjects: 24
Study 7986789 — intervention group
Group type: COMPARATOR
Intervention: Control periods (low-fibre basal diet)
Number of subjects: 24
Study 7986789 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental periods (carrot consumption)
Number of subjects: 24
Study 7986789 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of carrot (raw and processed)
Number of subjects: 24
Study 2607285 — intervention group
Group type: EXPERIMENTAL
Intervention: IRM
Number of subjects: 51
Study 2607285 — intervention group
Group type: EXPERIMENTAL
Intervention: EBA cement
Number of subjects: 51
Study 2607285 — intervention group
Group type: COMPARATOR
Intervention: Amalgam with Copalite
Number of subjects: 51
Study 2607285 — intervention group
Group type: COMPARATOR
Intervention: Negative controls
Number of subjects: 51
Study 2607285 — intervention group
Group type: EXPERIMENTAL
Intervention: IRM vs EBA cement
Number of subjects: 51
Study 4717846 — intervention group
Group type: EXPERIMENTAL
Intervention: Lincomycin
Number of subjects: 60
Study 7353190 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg by mouth
Number of subjects: 200
Study 7353190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 31109252 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with ASD and elevated anxiety symptoms
Number of subjects: 93
Study 30139293 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT-STAND (alternating sitting and standing every 30 minutes)
Number of subjects: 25
Study 30139293 — intervention group
Group type: COMPARATOR
Intervention: SIT (prolonged sitting)
Number of subjects: 25
Study 30139293 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT-STAND
Number of subjects: 25
Study 30139293 — intervention group
Group type: COMPARATOR
Intervention: SIT
Number of subjects: 25
Study 26800856 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over the contralesional PMd (900 pulses at 110% of the motor threshold)
Number of subjects: 10
Study 26800856 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (900 pulses at 0% of the motor threshold)
Number of subjects: 10
Study 23800393 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling for 72 hours
Number of subjects: 314
Study 23800393 — intervention group
Group type: COMPARATOR
Intervention: Standard care without cooling
Number of subjects: 314
Study 22318965 — intervention group
Group type: EXPERIMENTAL
Intervention: Trophic enteral feeds
Number of subjects: 185
Study 22318965 — intervention group
Group type: COMPARATOR
Intervention: Full-energy feeds
Number of subjects: 185
Study 19469604 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-determined motivation at the end of CR
Number of subjects: 68
Study 19469604 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological need satisfaction for competence
Number of subjects: 68
Study 17150279 — intervention group
Group type: EXPERIMENTAL
Intervention: CTLA4 haplotypes in men with self-limited and chronic infection
Number of subjects: 1274
Study 17150279 — intervention group
Group type: EXPERIMENTAL
Intervention: CTLA4 haplotypes in male end-of-treatment responders
Number of subjects: 1274
Study 17150279 — intervention group
Group type: EXPERIMENTAL
Intervention: CTLA4 polymorphisms
Number of subjects: 1274
Study 17150279 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha monotherapy or infection with HCV genotypes 1/4
Number of subjects: 1274
Study 17150279 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 1274
Study 15022578 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic liver disease
Number of subjects: 50
Study 10636270 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable positive T waves (group 1, n = 35)
Number of subjects: 536
Study 10636270 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease > or =1 in negative T waves (group 2, n = 361)
Number of subjects: 536
Study 10636270 — intervention group
Group type: COMPARATOR
Intervention: No change in negative T waves (group 3, n = 64)
Number of subjects: 536
Study 10636270 — intervention group
Group type: COMPARATOR
Intervention: Increase > or =1 in negative T waves (group 4, n = 76)
Number of subjects: 536
Study 8884559 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril (5-10 mg/day)
Number of subjects: 66
Study 8884559 — intervention group
Group type: COMPARATOR
Intervention: nifedipine (20-40 mg slow-release three times a day)
Number of subjects: 66
Study 8884559 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril (5-10 mg/day) in diabetic patients
Number of subjects: 66
Study 1304463 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE3 (2 mg orally every 2 weeks)
Number of subjects: 90
Study 1304463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 3982576 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 alpha-OH-vitamin D3 (1 microgram/day initially, 0.3 microgram/day after 6 months)
Number of subjects: 27
Study 3982576 — intervention group
Group type: COMPARATOR
Intervention: High doses of calcium carbonate (mean 9 +/- 5 g/day)
Number of subjects: 27
Study 3982576 — intervention group
Group type: COMPARATOR
Intervention: Control group (same treatment as before)
Number of subjects: 27
Study 31004370 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare costs for diabetic foot ulceration and amputation in diabetes in 2014-2015
Number of subjects: 0
Study 31004370 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulceration care
Number of subjects: 0
Study 31004370 — intervention group
Group type: EXPERIMENTAL
Intervention: Care in community, outpatient and primary settings
Number of subjects: 0
Study 31004370 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of stay for inpatients with ulceration
Number of subjects: 0
Study 31004370 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of diabetic foot ulcers prevalence
Number of subjects: 0
Study 28671097 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine Citrate Disodium
Number of subjects: 100
Study 28671097 — intervention group
Group type: COMPARATOR
Intervention: Mizolastine
Number of subjects: 100
Study 25558030 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage (15-minute gentle abdominal massage, administered twice daily for 3 days)
Number of subjects: 80
Study 25558030 — intervention group
Group type: COMPARATOR
Intervention: Control group (twice-daily 15-minute social interaction contact with the same nurse)
Number of subjects: 80
Study 23667615 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (fluticasone) for 30 months
Number of subjects: 64
Study 23667615 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 30 months
Number of subjects: 64
Study 23667615 — intervention group
Group type: COMPARATOR
Intervention: Current smokers vs ex-smokers
Number of subjects: 64
Study 21864817 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZES)
Number of subjects: 2332
Study 21864817 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 2332
Study 19755551 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shockwave treatment: one session weekly for four to six weeks
Number of subjects: 104
Study 19755551 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercises: two 45 minute sessions weekly for up to 12 weeks
Number of subjects: 104
Study 17341003 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761
Number of subjects: 400
Study 17341003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 14756388 — intervention group
Group type: COMPARATOR
Intervention: Perfalgan 1 g
Number of subjects: 24
Study 14756388 — intervention group
Group type: COMPARATOR
Intervention: Propacetamol 2 g
Number of subjects: 24
Study 14756388 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfalgan 0.5 g
Number of subjects: 24
Study 11318774 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (1200 microg dose)
Number of subjects: 8
Study 9227301 — intervention group
Group type: EXPERIMENTAL
Intervention: VVI pacing
Number of subjects: 30
Study 9227301 — intervention group
Group type: COMPARATOR
Intervention: DDI pacing
Number of subjects: 30
Study 8482617 — intervention group
Group type: EXPERIMENTAL
Intervention: Annular phased array applicator (60-80 MHz)
Number of subjects: 18
Study 8482617 — intervention group
Group type: COMPARATOR
Intervention: Sigma applicator (70-90 MHz)
Number of subjects: 18
Study 8482617 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 18
Study 3546936 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Doppler spectrum analysis measuring peak systolic frequency (PSF)
Number of subjects: 242